Skip to main content
Back to Global Brain Corporation

Global Brain Corporation's Biotechnology Portfolio

Browse 25 Biotechnology companies funded by Global Brain Corporation. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
25
Total Funding in Biotechnology
$302.0M

Biotechnology Portfolio Companies (25)

Export
Animal FeedAquacultureBiotechnologyConsumer ResearchOrganicRecyclingSustainability

Symbiobe is a research and development agency that effectively utilizes untapped natural biomass resources and photosynthetic organisms.

Kyoto, Japan
September 2024
$5.7M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

ThinkCyte is a biotechnology company that provides sorting of cells for various applications in research, diagnostics, and therapeutics.

Hongo, Japan
August 2024
$14.8M
Series C

Founder Contacts

30,000+ verified contacts

AnalyticsBig DataBiotechnologyHealth Care

Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services.

Tokyo, Japan
August 2024
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Bristol, United Kingdom
July 2023
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife ScienceMedical

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Cambridge, United Kingdom
July 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyConsumer SoftwareFitnessGeneticsMedical

Genomelink is a platform where people discover more with their DNA data and help businesses build, market, and do research with it.

Berkeley, United States
July 2021
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical Device

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

Holland, United States
June 2026
$45.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

AnalyticsBiotechnologyLife ScienceMedical

BitBiome sequences microbial genomes to support health research and improve biomanufacturing and industrial biotechnology processes.

Tokyo, Japan
May 2026
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.

Cambridge, United States
April 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsMachine LearningMedicalOncology

Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.

Tokyo, Japan
April 2025
$2.1M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareNeuroscienceTherapeutics

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Boston, United States
March 2026
$3.3M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareLife ScienceMedical

IgGenix is a biotechnology company.

San Francisco, United States
February 2023
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyChemical EngineeringLife Science

Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.

San Diego, United States
February 2025
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine Learning

Persist AI is a biotechnology company that builds long-acting microsphere formulations.

Woodland, United States
March 2025
$12.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Carlsbad, United States
February 2025
$3.8M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingMedicalRental

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

Kyoto, Japan
October 2024
$15.2M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

AgricultureBiotechnologyChemicalGeneticsLife ScienceManufacturing

Ac-Planta is an agri-biotech company that develops, manufactures, and sells biostimulant materials.

Tokyo, Japan
March 2024
$3.2M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

San Carlos, United States
March 2024
$12.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyCleanTechEnvironmental EngineeringHealth CareRenewable EnergySustainability

Visolis provides biomanufacturing solutions by combining synthetic biology and chemical catalysis to produce bio-based chemicals and fuels.

Hayward, United States
January 2026
$2.9M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

San Francisco, United States
December 2022
$10.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical Device

Immunosens is a medical device company that develops immunosensors for immunological tests.

Suita, Japan
November 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalNursing and Residential Care

EditForce develops drugs and seeds by using nucleic acid manipulation technologies.

Fukuoka, Japan
May 2021
$7.3M
Series Unknown

Founder Contacts

30,000+ verified contacts

Explore Global Brain Corporation's Full Portfolio

View all companies funded by Global Brain Corporation across every industry and funding stage.

View Full Global Brain Corporation Portfolio